EUVIMEDEUVIMED entdecken
FallberichtOpen Access

Transient Thyroiditis Followed by Exacerbation of Hypothyroidism After Immune Checkpoint Inhibitor Therapy (Nivolumab and Ipilimumab) in a Patient With Pre-existing Autoimmune Hypothyroidism: A Case Report

Guy Hayakawa, Maya M Leibowitz, Sudipta Datta, Samson O Oyibo

Cureus · 24.05.2023

DOI: 10.7759/cureus.39439 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Cureus, erschienen am 24.05.2023. Verfasst von Guy Hayakawa und 3 weiteren Autor:innen. Beteiligte Einrichtung: General Medicine, Peterborough City Hospital, Peterborough, GBR. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

autoimmune hypothyroidismcombination therapyimmune checkpoint inhibitorsipilimumablevothyroxinenivolumabtransient thyroiditis

Autor:innen und Institutionen

  • General Medicine, Peterborough City Hospital, Peterborough, GBR.
  • Oncology, Peterborough City Hospital, Peterborough, GBR.
  • Diabetes and Endocrinology, Peterborough City Hospital, Peterborough, GBR.

Zitieren

APA

Hayakawa, G., Leibowitz, M. M., Datta, S., & Oyibo, S. O. (2023). Transient Thyroiditis Followed by Exacerbation of Hypothyroidism After Immune Checkpoint Inhibitor Therapy (Nivolumab and Ipilimumab) in a Patient With Pre-existing Autoimmune Hypothyroidism: A Case Report. Cureus. https://doi.org/10.7759/cureus.39439

Vancouver

Hayakawa G, Leibowitz MM, Datta S, Oyibo SO. Transient Thyroiditis Followed by Exacerbation of Hypothyroidism After Immune Checkpoint Inhibitor Therapy (Nivolumab and Ipilimumab) in a Patient With Pre-existing Autoimmune Hypothyroidism: A Case Report. Cureus. 2023. doi:10.7759/cureus.39439

BibTeX
@article{Hayakawa2023,
  author = {Hayakawa, Guy and Leibowitz, Maya M and Datta, Sudipta and Oyibo, Samson O},
  title = {Transient Thyroiditis Followed by Exacerbation of Hypothyroidism After Immune Checkpoint Inhibitor Therapy (Nivolumab and Ipilimumab) in a Patient With Pre-existing Autoimmune Hypothyroidism: A Case Report},
  journal = {Cureus},
  year = {2023},
  doi = {10.7759/cureus.39439}
}
Kostenlos starten →